You are here:
02 June 2017 / article

Borderline products: Cranberry products cannot be regarded as medical devices

The European Commission’s Regulatory Committee on Medical Devices has adopted a Commission Decision on the qualification of cranberry products.

According to the Decision, cranberry products do not fall within the definition of medical devices set out in the Medical Devices Directive.  

The European Commission’s Regulatory Committee on Medical Devices has adopted a Commission Implementing Decision on the qualification of cranberry products. The Decision states that products “whose principal intended action, depending on proanthocyanidins present in cranberry (Vaccinium Macrocarpon)extract, is to prevent or treat cystitis”, are not medical devices within the meaning of Article 1 (2) (a) of the Medical Devices Directive.

Pharmacological and not a mechanical

The Decision was taken upon the request from France in accordance with Article 13 (1) (d) of the Medical Devices Directive. It also follows the European Medicines Agency’s (EMA) scientific opinion of 22 July 2016 which noted that “Products containing proanthocyanidins and/or cranberry as substance or preparation for use in urinary tract infections are currently marketed differently across the EU as food supplement, medical device or consumer product”. Furthermore, EMA concluded that the principal intended action of this group of products is most probably pharmacological and not a mechanical mode which would qualify them as medical devices.

Food supplements or medicinal products?

It will nevertheless be up to the Members States’ competent authorities to determine whether these products are food supplements or medicinal products. Should they be considered as food supplements, all health-related communications regarding those products will fall within the scope of the Nutrition and Health Claims Regulation.

The formal adoption and publication of the Decision are planned later this summer.



Ultimate beneficial owners become public in the UBO register

Ultimate beneficial owners become public in the UBO register

Ultimate beneficial owners (hereafter UBOs) of all Belgian companies and foundations have to register in the new Belgian UBO register by 30 November 2018 at... read more
New definition of enterprise: Belgian civil law partnerships become public

New definition of enterprise: Belgian civil law partnerships become public

Belgian civil law partnerships are subject to few formalities under current legislation. At present, they do not have to be registered, nor do they have to keep... read more
Tax Controversy Leaders Guide - 2018 edition - Loyens & Loeff

Loyens & Loeff experts recognised as Tax Controversy Leaders in Belgium

Christian Chéruy, Thierry Charon and Caroline Docclo are recognised as Tax Controversy Leaders in Belgium in the 8th edition of the Tax Controversy Leaders guide,... read more